Aptinyx to Report Second Quarter Financial Results on Thursday, August 13, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical
company developing transformative therapies for the treatment of
brain and nervous system disorders, today announced that the
company will host a conference call and live webcast on Thursday,
August 13, 2020 at 5:00 p.m. ET to report second quarter 2020
financial results and discuss recent business highlights.
To access the live conference call, please dial (833) 772-0394
(domestic) or (236) 738-2205 (international) and refer to
conference ID 5118404. A live audio webcast of the event will be
available on the Investors & Media section of Aptinyx’s website
at https://ir.aptinyx.com. A replay of the webcast will be archived
on Aptinyx’s website for 30 days following the event.
Aptinyx Inc. is a clinical-stage biopharmaceutical company
focused on the discovery, development, and commercialization of
proprietary synthetic small molecules for the treatment of brain
and nervous system disorders. Aptinyx has a platform for discovery
of novel compounds that work through a unique mechanism to
modulate—rather than block or over-activate—NMDA receptors and
enhance synaptic plasticity, the foundation of neural cell
communication. The company has three product candidates in clinical
development in central nervous system indications, including
chronic pain, post-traumatic stress disorder, and cognitive
impairment associated with Parkinson’s disease. Aptinyx is also
advancing additional compounds from its proprietary discovery
platform, which continues to generate a rich and diverse pipeline
of small-molecule NMDA receptor modulators with the potential to
treat an array of neurologic disorders. For more information, visit
Source: Aptinyx Inc.
version on businesswire.com: https://www.businesswire.com/news/home/20200730005993/en/
Investor & Media Contact: Nick Smith Aptinyx Inc.
email@example.com or firstname.lastname@example.org 847-871-0377